Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

AVI and Eleos sign crosslicense agreement for p53 antisense drugs

Jan. 12, 2007

Low-dose, high-dose intensity decitabine beneficial in myelodysplastic syndrome

Jan. 12, 2007

TheraSphere approved to treat HCC patients with portal vein thrombosis

Jan. 11, 2007

Dll4/Notch blockade leads to nonproductive angiogenesis and tumor hypoxia

Jan. 11, 2007

Erbitux plus FOLFIRI increases PFS in metastatic colorectal cancer

Jan. 11, 2007

Doxil approved in Japan for AIDS-related Kaposi's sarcoma

Jan. 11, 2007

Novel anticancer drugs revealed in recent patents

Jan. 11, 2007

FDA grants orphan drug status to Xanafide in AML

Jan. 11, 2007

Vorinostat active in phase II refractory cutaneous T-cell lymphoma trial

Jan. 11, 2007

MPC-7869 development discontinued in cancer

Jan. 11, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...